Printer Friendly

Browse Enzyme inhibitors topic



1-248 out of 248 article(s)
Title Author Type Date Words
Reversal of insecticide resistance in Florida populations of Diaphorina citri (Hemiptera: Liviidae). Coy, Monique R.; Bin, Liu; Stelinski, Lukasz L. Report Mar 1, 2016 7029
Drug counters effects of excessive inflammation arising from immune disorder. Jan 29, 2016 944
Procurement of chlorpyrifos 20percentage e.C. Jan 14, 2016 113
Antileishmanial activity and trypanothione reductase effects of terpenes from the Amazonian species Croton cajucara Benth (Euphorbiaceae). Lima, Gerson S.; Castro-Pinto, Denise B.; Machado, Gerzia C.; Maciel, Maria A.M.; Echevarria, Aurea Report Nov 15, 2015 4038
LSK BioPharma and Huntsman Cancer Institute Announce an Exclusive License Agreement for HCI-1401, a BTK inhibitor for treatment of B-cell malignancies and other diseases. Aug 6, 2015 749
Potential inhibitory effect of 4-hydroxytoremifene on CYP2J2 activities in human liver microsomes. Phuc, Nguyen Minh; Wu, Zhexue; Lee, Eun Young; Liu, Kwang-Hyeon Report Aug 1, 2015 2564
Delivery antibacterial agents for systemic use - imipenem and enzyme inhibitor. Jun 4, 2015 123
Delivery antibacterial agents for systemic use - ampicillin and enzyme inhibitor. Jun 4, 2015 123
Delivery antibacterial agents for systemic use - piperacillin and enzyme inhibitor. Jun 4, 2015 123
Delivery antibacterial agents for systemic use - amoxicillin and enzyme inhibitor. Jun 4, 2015 123
Delivery antibacterial agents for systemic use - piperacillin and enzyme inhibitor. Jun 4, 2015 122
Delivery antibacterial agents for systemic use - imipenem and enzyme inhibitor. Jun 4, 2015 124
Delivery antibacterial agents for systemic use - ampicillin and enzyme inhibitor. Jun 4, 2015 124
Delivery antibacterial agents for systemic use - amoxicillin and enzyme inhibitor. Jun 4, 2015 124
Actavis Launches NAMZARIC(TM) (memantine hydrochloride extended-release and donepezil hydrochloride), a Fixed-Dose Combination Therapy for the Treatment of Moderate to Severe Alzheimer's Disease. May 18, 2015 1771
Drugs and the kidney. Naidoo, S.; Meyers, A.M. Report Apr 1, 2015 3294
United States : EPA Revised Chlorpyrifos Assessment Shows Risk to Workers. Jan 6, 2015 324
Actavis and Adamas Announce FDA Approval of Namzaric(TM), a Fixed-Dose Combination of Memantine Extended-Release and Donepezil Hydrochloride. Dec 24, 2014 1717
Data from Clinical Study of Pharmalink's Nefecon to be Presented at American Society of Nephrology's Kidney Week 2014. Clinical report Nov 3, 2014 1076
Data from Clinical Study of Pharmalink's Nefecon to be Presented at American Society of Nephrology's Kidney Week 2014. Clinical report Nov 3, 2014 1081
Baicalein protects against hypertension associated with diabetes: effect on vascular reactivity and stiffness. El-Bassossy, Hany M.; Hassan, Noura Ahmed; Mahmoud, Mona Fouad; Fahmy, Ahmed Report Oct 15, 2014 2922
Syncope secondary to second-degree atrioventricular block with donepezil use. Hundae, Aneley; Afzal, Aasim; Assar, Manish D.; Schussler, Jeffrey M. Report Oct 1, 2014 713
Salvianolic acid A, a matrix metalloproteinase-9 inhibitor of Salvia miltiorrhiza, attenuates aortic aneurysm formation in apolipoprotein E-deficient mice. Zhang, Tingting; Xu, Jinghua; Li, Defang; Chen, Jing; Shen, Xu; Xu, Feng; Teng, Fukang; Deng, Yanpin Report Aug 27, 2014 5614
Protein Structural Defects Are Enablers and Stimulators of Enzyme Catalysis, Scientist Ariel Fernandez Finds. Jul 14, 2014 557
Green tea daily reduces pancreatic cancer risk: Study. Report Jul 12, 2014 229
Green tea daily reduces pancreatic cancer risk: Study. Report Jun 30, 2014 229
Green tea daily reduces pancreatic cancer risk: Study. Report Jun 1, 2014 229
United States : OTSUKA PHARMA receives rights for hematological cancer treatment DacogenA and an enzyme inhibitor E7727 from EISAI. Apr 4, 2014 150
Benign prostat hiperplazisi ile iliskili alt uriner sistem semptomlannin tedavisinde fosfodiesteraz tip-5 inhibitorlerinin rolu / The role of phosphodiesterase type-5 inhibitors in treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia. Umul, Mehmet; Serel, Tekin Ahmet Report Dec 1, 2013 4377
ACE/ARB combo raised risks in diabetic nephropathy. Worcester, Sharon Dec 1, 2013 683
Effect of alginate and alginate-cimetidine combination therapy on stimulated postprandial gastro-oesophageal reflux. Clinical report Nov 1, 2013 292
Mark Schnute to Speak at Protein Kinases Drug Design Oct 24-25, 2013 -San Diego. Sep 7, 2013 474
Evaluation of antioxidant activity of the extract n-Butanol and ethyl acetate of Catha Edulis from Yemen. Algabr, Methaq. Nasser.; Ameddah, S.; Menad, A.; Mekkiou, R.; Benayache, S.; Benayache, F. Report Sep 1, 2013 2229
Adverse benzo[a]pyrene effects on neurodifferentiation are altered by other neurotoxicant coexposures: interactions with dexamethasone, chlorpyrifos, or nicotine in PC12 cells. Slotkin, Theodore A.; Card, Jennifer; Seidler, Frederic J. Report Jul 1, 2013 5338
Erratum/Duzeltme. Correction notice Jun 1, 2013 231
1,2,3,4,6 Penta-O-galloyl-[beta]-D-glucose, a bioactivity guided isolated compound from Mangifera indica inhibits 11[beta]-HSD-1 and ameliorates high fat diet-induced diabetes in C57BL/6 mice. Mohan, C.G.; Viswanatha, G.L.; Savinay, G.; Rajendra, C.E.; Halemani, Praveen D. Report May 15, 2013 7737
The evolving role of mTOR inhibition in transplantation tolerance. Brief article May 1, 2013 110
The effects of chronic usage of enzyme inhibitors and angiotensin receptor blockers on contrast-induced nephropathy in low-risk patients/ Dusuk riskli hastalarda anjiyotensin donusturucu enzim inhibitorleri ve anjiyotensin reseptor blokerlerinin kronik kullaniminin kontrast madde nefropatisi uzerine etkileri. Baris, Nezihi; Ozpelit, Ebru; Dogan, Nazile Bilgin; Kangul, Hande; Gul, Sefa; Akdeniz, Bahri; Guneri Report May 1, 2013 4355
3'-R/S-hydroxyvoacamine, a potent acetylcholinesterase inhibitor from Tabernaemontana divaricata. Chaiyana, Wantida; Schripsema, Jan; Ingkaninan, Kornkanok; Okonogi, Siriporn Report Apr 15, 2013 4362
Alzheimer Disease - New Drugs, Markets and Companies - 2013. Mar 19, 2013 787
Molecular modeling, structural analysis and identification of ligand binding sites of trypanothione reductase from Leishmania mexicana. Mutlu, Ozal Report Mar 1, 2013 3066
Digestive juices blamed in shock: enzymes leaking from gut may have deadly consequences. Seppa, Nathan Feb 23, 2013 369
Enzyme kinetic and molecular docking studies for the inhibitions of miltirone on major human cytochrome P450 isozymes. Zhou, Xuelin; Wang, Yan; Hu, Tao; Or, Penelope M.Y.; Wong, John; Kwan, Yiu Wa; Wan, David C.C.; Hoi, Report Feb 15, 2013 5070
Influence of concurrent medications on outcomes of men with prostate cancer included in the TAX 327 study. Niraula, Saroj; Pond, Greg; de Wit, Ronald; Eisenberger, Mario; Tannock, Ian F.; Joshua, Anthony M. Report Feb 1, 2013 3499
Ganoderol B: a potent a-glucosidase inhibitor isolated from the fruiting body of Ganoderma lucidum. Brief article Feb 1, 2013 158
Hyperparathyroidism - Analysis and Market Forecasts to 2019. Nov 13, 2012 1493
Troponin I measured by a high-sensitivity assay in patients with suspected reversible myocardial ischemia: data from the Akershus Cardiac Examination (ACE) 1 study. Rosjo, Helge; Kravdal, Gunnhild; Hoiseth, Arne Didrik; Jorgensen, Marit; Badr, Pirouz; Roysland, Rag Report Nov 1, 2012 6247
Research and Markets: Global Enzyme Inhibitors Market 2011-2015 Report Discusses That the Patent Expiry of Top-Selling Drugs Is a Challenge for the Market. Oct 15, 2012 355
Morpho-toxicology of chlorpyrifos to prolactin cells of a freshwater catfish, Heteropneustes fossilis/Morfotoxicologia de clorpirifos para as celulas de prolactina de bagre de agua doce Heteropneustes fossilis. Srivastav, Ajai Kumar; Srivastava, Sanjay Kumar; Tripathi, Sarojni; Mishra, Diwakar; Srivastav, Suni Oct 1, 2012 3883
Research and Markets: Alzheimer Disease - New Drugs, Markets and Companies - Updated 2012 Report. Report Sep 6, 2012 618
Kinase Inhibitors: Global Markets -- Focus on the U.S. Company overview Sep 6, 2012 5589
Global Markets for Enzyme Inhibitors. Sep 6, 2012 5252
Kinase Inhibitors: Global Markets -- Focus on Asia. Company overview Sep 4, 2012 5463
Kinase Inhibitors: Global Markets -- Focus on Europe. Company overview Sep 4, 2012 5491
Kinase Inhibitors: Global Markets -- Focus on Emerging Markets. Company overview Sep 4, 2012 5497
Global Markets for Enzyme Inhibitors -- Focus on the US. Company overview Sep 4, 2012 6476
Global Markets for Enzyme Inhibitors -- Focus on Europe. Company overview Sep 4, 2012 6417
Mildly reduced preoperative ejection fraction increases the risk of stroke in older adults undergoing Coronary Artery Bypass Grafting. Reyes, Bernardo; Trotter, Chase; Richards, Mark; Ladd, Jennifer; Broce, Mike; Kali, Maher; Groves, S Report Sep 1, 2012 3206
Global Markets for Enzyme Inhibitors. Company overview Aug 28, 2012 6832
Global Markets for Enzyme Inhibitors -- Focus on Emerging Markets. Company overview Aug 28, 2012 6500
Synergetic effect of testosterone and phophodiesterase-5 inhibitors in hypogonadal men with erectile dysfunction: A systematic review. Alhathal, Naif; Elshal, Ahmed M.; Carrier, Serge Report Aug 1, 2012 4428
First Clinical Data for BACE Inhibitor E2609 Showcased at International Alzheimer's Conference. Conference news Jul 23, 2012 1400
Eisai Presents First Clinical Data for BACE Inhibitor E2609 at Alzheimer's Association International Conference 2012. Clinical report Jul 19, 2012 703
Eisai to Present First Clinical Data for BACE Inhibitor E2609 at Alzheimer's Association International Conference 2012. Conference news Jul 13, 2012 358
Newly discovered mechanism for chlorpyrifos effects on neurodevelopment. Potera, Carl Report Jul 1, 2012 1344
Pesticide residue determination in Shahr-e-Rey tomatoes using Quechers method. Yadolahi, Mahboubeh; Babri, Mehran; Sharif, Amir Abdolah Mehrdad; Khaneghah, Amin Mousavi Report Jul 1, 2012 2682
Global Markets for Enzyme Inhibitors. Company overview Jun 26, 2012 6857
Emerging Markets for Enzyme Inhibitors Surge, To Grow More Than 50% by 2016. Jun 25, 2012 863
Acneiform eruption and other dermatologic side effects induced by targeted cancer therapy: a retrospective analysis/Hedefe yonelik kemoterapi ilaclarina bagli akneiform dokuntu ve eslik eden diger dermatolojik yan etkiler: retrospektif bir degerlandirme. Yazganoglu, Kurtulus Didem; Baykal, Can Report Jun 1, 2012 3848
Prenatal exposure to insecticide chlorpyrifos may alter infants' brain structure. May 1, 2012 495
Naturopathic management of infections of the heart and their sequelae. Mikolai, Jeremy; Wilner, Martin Clinical report May 1, 2012 8211
Canadian Consensus Conference: The FDA decision on the use of 5ARIs. Klotz, Laurence; Chetner, Michael; Chin, Joseph; Finelli, Tony; Fleshner, Neil; Fradet, Yves; Golden Report Apr 1, 2012 3204
Digestive enzymes in small intestine linked to shock. Mar 22, 2012 120
Alzheimer Disease - New Drugs, Markets and Companies. Jan 3, 2012 6391
Hypertension in goldminers. Maepe, L.M.; Outhoff, K. Report Jan 1, 2012 3054
South African hypertension guideline 2011. Seedat, Y.K.; Rayner, B.L. Report Jan 1, 2012 16016
Blood pressure meds may slow bone loss in men. Clinical report Jan 1, 2012 333
Protective and ameliorative effects of mate (Ilex paraguariensis) on metabolic syndrome in TSOD mice. Husseina, Ghazi M.E.; Matsuda, Hisashi; Nakamura, Seikou; Akiyama, Toshihito; Tamura, Kouhei; Yoshik Report Dec 15, 2011 7183
Virobay's Spectrum-Selective Cathepsin Inhibitor Shows Efficacy in Bone Cancer Model. Nov 14, 2011 722
Research and Markets: Alzheimer Disease - New Drugs, Markets and Companies. Oct 24, 2011 627
Research and Markets: Kinetics of Enzyme Action: Essential Principles for Drug Hunters. Oct 18, 2011 327
Ganoderol B: a potent [alpha]-Glucosidase inhibitor isolated from the fruiting body of Ganoderma lucidum. Fatmawati, Sri; Shimizu, Kuniyoshi; Kondo, Ryuichiro Report Sep 15, 2011 2553
Keynote address. Report Sep 1, 2011 215
Dyax Announces Treatment of First Patient in Phase 2 Trial of Ecallantide for Acute Treatment of ACE Inhibitor-Induced Angioedema. Aug 4, 2011 1092
Determinants of agricultural pesticide concentrations in carpet dust. Gunier, Robert B.; Ward, Mary H.; Airola, Matthew; Bell, Erin M.; Colt, Joanne; Nishioka, Marcia; Me Report Jul 1, 2011 7813
The role of Ginkgo biloba extract in the integrative management of dementia. Wheat, Janelle M.; Currie, Geoffrey M.; Kiat, Hosen Report Jun 22, 2011 6317
Biomarker of exposure for chlorpyrifos. Brief article Jun 1, 2011 120
Biomarkers of chlorpyrifos exposure and effect in Egyptian cotton field workers. Farahat, Fayssal M.; Ellison, Corie A.; Bonner, Matthew R.; McGarrigle, Barbara P.; Crane, Alice L.; Report Jun 1, 2011 6699
Acoustic detection of arthropod infestation of grape roots: scouting for grape root borer (Lepidoptera: Sesiidae). Sanders, William R.; Mankin, R.W.; Liburd, Oscar E.; Stelinski, Lukasz L. Report Jun 1, 2011 4303
Complexity of prescriptions impairs adherence. Moon, Mary Ann Jun 1, 2011 876
Ellagitannins from Phyllanthus muellerianus (Kuntze) Exell.: geraniin and furosin stimulate cellular activity, differentiation and collagen synthesis of human skin keratinocytes and dermal fibroblasts. Agyare, Christian; Lechtenberg, Matthias; Deters, Alexandra; Petereit, Frank; Hensel, Andreas May 15, 2011 6713
Reportlinker Adds Alzheimer disease - New drugs, markets and companies. May 2, 2011 757
Efficient synthesis of a novel class of 1, [omega]-bis(triazoles) and 1, [omega]-bis[[l,2,4]triazolo[3,4-b][l,3,4]thiadiazoles] with potential antimicrobial activity. Khalil, Nasser S.A.M. May 1, 2011 14937
Reportlinker Adds Alzheimer Disease - New Drugs, Markets and Companies. Apr 4, 2011 817
Landmark Ruling Comes Into Effect: Treatment now Available for People With Mild Alzheimer's at Time of Diagnosis. Mar 22, 2011 1521
Jury out on scleroderma renal crisis prophylaxis. Mahoney, Diana Clinical report Mar 15, 2011 593
Stop that clot: haemostasis and anticoagulation: this is the first in a series of clinical articles Kai Tiaki Nursing New Zealand is publishing to provide a convenient way for nurses to earn continuing professional development hours. Casey, Georgina Report Feb 1, 2011 4569
The impact of Medicare Part D on medication treatment of hypertension. Zhang, Yuting; Donohue, Julie M.; Lave, Judith R.; Gellad, Walid F. Report Feb 1, 2011 5585
Predicting cyclooxygenase inhibition by three-dimensional pharmacophoric profiling. Part II: identification of enzyme inhibitors from Prasaplai, a Thai traditional medicine. Waltenberger, Birgit; Schuster, Daniela; Paramapojn, Sompol; Gritsanapan, Wandee; Wolber, Gerhard; R Report Jan 15, 2011 7359
Research and Markets: Alzheimer Disease - An Updated Report on New Drugs, Markets and Companies. Report Jan 4, 2011 617
Control and treatment profiles of 70,889 adult type 2 diabetes mellitus patients in Malaysia--a cross sectional survey in 2009. Mastura, Ismail; Chew, Boon How; Lee, Ping Yein; Cheong, Ai Theng; Sazlina, Shariff Ghazali; Jamaiya Jan 1, 2011 6171
Cancer Targeted Technology Enters into a Research and License Option Agreement with Bayer Pharma AG to Advance a Cancer PET Imaging Agent toward Clinical Trials. Dec 14, 2010 397
Boehringer Ingelheim Initiates Phase III Clinical Trial With Afatinib in Advanced Breast Cancer. Dec 8, 2010 1312
U.S. Patent Issued for New Method for Treating Cognitive Disorders. Dec 6, 2010 571
Surprisingly Few Surveyed Neurologists in the EU5 Are Familiar With Late-Stage Emerging Therapies for Alzheimer's Disease. Nov 15, 2010 774
Epizyme Awarded $733,000 Grant under Qualified Therapeutic Discovery Project Program. Nov 3, 2010 393
Effect of carbamate-pesticides and sewage--sludge on growth and trace elements concentration in wheat plants. Bansal, O.P. Nov 1, 2010 4488
Milestone Ruling for Alzheimer's Disease Patients Announced. Oct 6, 2010 1498
New and established targets for the treatment of breast cancer. Man, Yik L.; Filipovic, Aleksandra; Stebbing, Justin; Giamas, Georgios Sep 1, 2010 3380
Cardiac health following drug treatment for breast cancer. Verrill, Mark Jul 1, 2010 3407
Cholinesterase depression and its association with pesticide exposure across the agricultural season among Latino farmworkers in North Carolina. Quandt, Sara A.; Chen, Haiying; Grzywacz, Joseph G.; Vallejos, Quirina M.; Galvan, Leonardo; Arcury, Report May 1, 2010 5700
Association between renin-angiotensin-aldosterone system blockers and postoperative atrial fibrillation in patients with mild and moderate left ventricular dysfunction/Hafif ve orta derecede sol ventrikul disfonksiyonu olan hastalarda renin-anjiyotensin-aldosteron sistem blokerleri ile kalp cerrahisi sonrasi gelisen atrial fibrilasyon arasindaki iliski. Ozaydin, Mehmet; Varol, Ercan; Turker, Yasin; Peker, Oktay; Erdogan, Dogan; Dogan, Abdullah; Ibrisim Clinical report Apr 1, 2010 4945
Pesticide chlorpyrifos associated with childhood developmental delays. Mar 21, 2010 465
Acetylon Licenses Powerful Discovery Methodology and Platform from Harvard University and the Dana-Farber Cancer Institute for Development of Further Next-Generation Class II-Selective HDAC Inhibitor Compounds. Mar 8, 2010 1089
Acetylcholinesterase enzyme inhibitory potential of standardized extract of Trigonella foenum graecum L and its constituents. SatheeshKumar, N.; Mukherjee, Pulok K.; Bhadra, S.; Saha, B.P. Clinical report Mar 1, 2010 2989
Beta-lactamase inhibitory component from the roots of Fissistigma cavaleriei. Yang, Zaichang; Niu, Yule; Le, Yi; Ma, Xiaoyan; Qiao, Chong Report Feb 1, 2010 1987
Silver impairs neurodevelopment: studies in PC12 cells. Powers, Christina M.; Wrench, Nicola; Ryde, Ian T.; Smith, Amanda M.; Seidler, Frederic J.; Slotkin, Report Jan 1, 2010 6920
The implications of using a physiologically based pharmacokinetic (PBPK) model for pesticide risk assessment. Lu, Chensheng; Holbrook, Christina M.; Andres, Leo M. Report Jan 1, 2010 7046
Is the epidermal growth factor receptor status in lung cancers reflected in clinicopathologic features? Inamura, Kentaro; Ninomiya, Hironori; Ishikawa, Yuichi; Matsubara, Osamu Report Jan 1, 2010 4681
Well-water consumption and Parkinson's disease in rural California. Gatto, Nicole M.; Cockburn, Myles; Bronstein, Jeff; Manthripragada, Angelika D.; Ritz, Beate Report Dec 1, 2009 8686
Nycomed and Forest Laboratories to Collaborate on Daxas[R] (roflumilast) for COPD. Aug 10, 2009 1286
Inkjet printer technology may be used to make toxin-detecting biosensors. Jul 14, 2009 357
Comparison of methods for the extraction of genomic DNA from aerobic digest. Blankinship, Lisa Ann Report Jul 1, 2009 5881
Updates on lupus and pregnancy. Jul 1, 2009 4286
Interim Analysis of Long-Term Data with ONGLYZA,ao (saxagliptin) When Added to Metformin in People with Inadequately Controlled Type 2 Diabetes Present. Jun 7, 2009 1826
Interim Analysis of Long-Term Data with ONGLYZA[TM] (saxagliptin) When Added to Metformin in People with Inadequately Controlled Type 2 Diabetes Presented at ADA Annual Scientific Sessions. Jun 6, 2009 1722
Thyroid carcinoma recommendations updated. McNamara, Damian Jun 1, 2009 934
The effect of the content of the knowledge on adherence to medication in hypertensive patients/Hipertansiyonlu hastalarda bilgi iceriginin ilac tedavisi uyumuna etkisi. Karaeren, Hayrettin; Yokusoglu, Mehmet; Uzun, Senay; Baysan, Oben; Koz, Cem; Kara, Belguzar; Kirilma Clinical report Jun 1, 2009 3429
Morphogenomics and morphoproteomics: a role for anatomic pathology in personalized medicine. Brown, Robert E. Report Apr 1, 2009 9120
1,6-0, 0-diacetylbritannilactones inhibits I[kappa]B kinase [beta]-dependent NF-[kappa]B activation. Liu, Yue-Ping; Wen, Jin-Kun; Wu, Yi-Bing; Zhang, Jia; Zheng, Bin; Zhang, Di-Qun; Han, Mei Report Mar 1, 2009 2735
Inhibitory effect of rhetsinine isolated from Evodia rutaecarpa on aldose reductase activity. Kato, A.; Yasuko, H.; Goto, H.; Hollinshead, J.; Nash, R.J.; Adachi, I. Report Mar 1, 2009 2492
The quality of arterial hypertension treatment in cardiology service in Kosovo--a single center study/Kosova kardiyoloji servisinde arteryel hipertansiyon tedavi niteligi-tek merkez calismasi. Bajraktari, Gani; Sylejmani, Xhevahire; Thaci, Kimete; Elezi, Shpend; Ndrepepa, Gjin Clinical report Mar 1, 2009 4222
Research and Markets: Analyse Profiles of 134 Companies Involved in Developing Diagnostics and Therapeutics for Alzheimer's Disease Are Presented along with 101 Collaborations. Feb 5, 2009 528
A Phase I study of full-dose gemcitabine and regional arterial infusion of nafamostat mesilate for advanced pancreatic cancer. Carrato, Alfredo; Guillen-Ponce, Carmen Dec 1, 2008 866
A Comprehensive Analysis of the Production and Marketing of Chlorpyrifos in China: Understand the Current Market, Issues & Forecasts to 2013. Oct 24, 2008 344
Agency: Chemicals a danger to salmon. Aug 6, 2008 777
Tracheal diverticulum: a rare finding in a patient with worsening chronic cough. Danielson, Gregory P.; Jedlovszky, Veronika; Landrigan, Gary P. Clinical report Aug 1, 2008 1150
Bristol-Myers Squibb and AstraZeneca Submit New Drug Application in the United States and Marketing Authorization Application in Europe for ONGLYZA(TM) (saxagliptin) for the Treatment of Type 2 Diabetes. Jul 23, 2008 631
ONGLYZA(TM) (saxagliptin) Demonstrated Significant Reductions in Key Measures of Glucose Control in Treatment Naive People with Type 2 Diabetes. Jun 7, 2008 1754
Alzheimer's--potential cure. Bateman, Chris Brief article Jun 1, 2008 80
ARIAD Initiates Phase 1 Clinical Trial of its Investigational Oral Multi-Targeted Kinase Inhibitor, AP24534, in Patients with Hematological Cancers. May 22, 2008 1415
Plexxikon Announces Preclinical Data Demonstrating Dramatic Improvement in Key Symptoms of Polycystic Kidney Disease. May 21, 2008 991
Gloucester Pharmaceuticals Announces Positive Results from Phase 2b Registration Trial of Romidepsin in Refractory CTCL. Financial report May 19, 2008 1047
VioQuest Pharmaceuticals Announces Upcoming Lenocta(TM) Oral Presentation at the American Society of Clinical Oncology Annual Meeting. May 19, 2008 782
Lev Pharmaceuticals to Present at the Rodman and Renshaw 5th Annual Global Healthcare Conference. Conference news May 13, 2008 588
Results Published in JACC Show Clinical Advantage of Switching to Angiomax from Heparin in Acute Coronary Syndrome Patients Undergoing Early Invasive Treatment. May 5, 2008 1187
Lev Announces FDA Advisory Committee Unanimously Recommends Approval of Cinryze(TM) for Hereditary Angioedema. May 2, 2008 1394
Coversyl(R) Protects Hypertensive Patients Against New-Onset Diabetes. May 1, 2008 1115
Potential New Oral Treatment May Revolutionise Management of Deadly Hepatitis C Virus. Apr 26, 2008 1089
Data Suggests Promising Overall Survival and Progression-Free Survival With VARGATEF(TM) (BIBF 1120). Clinical report Apr 25, 2008 1498
Telaprevir-Based PROVE Studies Show Significantly Higher SVR Rates in Treatment-Naive Genotype 1 Hepatitis C Patients in Half the Time of Current Treatments. Apr 23, 2008 1706
Nereus Pharmaceuticals Initiates Combination Clinical Trial for Proteasome Inhibitor NPI-0052 in Solid Tumors. Apr 18, 2008 605
VioQuest Pharmaceuticals' Novel Akt Inhibitor VQD-002 is Synergistic with Various Cancer Therapies in Preclinical Studies. Apr 16, 2008 1033
Cyclacel Pharmaceuticals Presents Insights into the Mechanisms of Its Cell Cycle Inhibitor Drugs. Apr 16, 2008 1096
Lev Pharmaceuticals Announces Submission of Complete Response to FDA for Cinryze(TM) for Hereditary Angioedema. Apr 15, 2008 778
Lev Pharmaceuticals Announces Agreement to Sell Intermediate Plasma Products to Biotest AG. Apr 15, 2008 572
Curis Announces Preclinical Efficacy Data for CUDC-101 at AACR Annual Meeting 2008. Apr 14, 2008 1004
ArQule Summarizes Abstracts Presented at AACR. Apr 14, 2008 639
Avalon Pharmaceuticals Identifies Small Molecule Inhibitors of the Aurora/Centrosome Cancer Pathway that Block PLK3 Protein Function. Apr 14, 2008 405
AVEO Pharmaceuticals' Novel Triple VEGF Receptor Inhibitor Shows Tumor Regression in Patients with Advanced Renal Cancer; Clinical Activity and Tolerability in other Solid Tumors including Colon and Lung Cancers. Apr 14, 2008 1043
U3 Pharma Achieves Preclinical Proof of Concept for U3-1287 (AMG 888). Apr 13, 2008 434
Ortho Biotech Oncology Research & Development Unites Johnson & Johnson Biopharmaceutical Oncology R&D Assets. Apr 11, 2008 1229
New Clinical Data on AVEO Pharmaceuticals' Investigational Triple VEGFR Small Molecule Inhibitor AV-951 to be Presented at AACR Annual Meeting. Apr 8, 2008 586
Cyclacel Pharmaceuticals Announces Multiple Presentations at American Association of Cancer Research Annual Meeting. Apr 7, 2008 767
Curis Announces Presentation at the 235th American Chemical Society National Meeting. Apr 7, 2008 1038
Avalon Pharmaceuticals to Present at the American Association for Cancer Research 2008 Annual Meeting. Apr 7, 2008 394
Metabasis Therapeutics Presents the Discovery of Its Second-Generation FBPase Inhibitor, MB07803, at the 235th American Chemical Society National Meeting. Apr 7, 2008 1071
Duodenogastroesophageal reflux and its effect on extraesophageal tissues: a review. Blumin, Joel H.; Merati, Albert L.; Toohill, Robert J. Apr 1, 2008 3087
Vertex Pharmaceuticals Announces Acceptance of Late-Breaker Abstract on Telaprevir, Investigational HCV Protease Inhibitor, for Presentation at EASL Annual Meeting. Mar 31, 2008 551
BWA Water Additives Introduces Belcor(R) 585 - A Unique Multifunctional Corrosion Inhibitor for Industrial Water Systems. Mar 31, 2008 343
Novel Oral Anticoagulant Pradaxa(R) (dabigatran etexilate) Approved by the European Commission. Mar 27, 2008 1533
Lev Presents Results of Phase III Study Supporting Safety and Efficacy of Cinryze(TM) (C1 inhibitor) as Prophylactic Therapy for HAE. Mar 18, 2008 1280
Lev Pharmaceuticals to Present at the Cowen and Company 28th Annual Healthcare Conference. Conference news Mar 14, 2008 275
Lev Announces FDA's Blood Products Advisory Committee to Review Cinryze (TM) (C1 inhibitor). Mar 13, 2008 950
ArQule Enrolls First Patient in Phase 1/2 Clinical Trial Program of ARQ 197 in Non-Small Cell Lung Cancer. Mar 13, 2008 1081
Vertex Pharmaceuticals and Tibotec Announce Start of Phase 3 'ADVANCE' Study with Telaprevir in Treatment-Naive, Genotype 1 HCV Patients. Clinical report Mar 13, 2008 1345
Clinical Data on Lenocta(TM), a Protein Tyrosine Phosphatase Inhibitor in Development at VioQuest Pharmaceuticals, Accepted for Oral Presentation at ASCO. Mar 10, 2008 762
The Global Market for Angiogenesis Therapeutic Products is Projected to Reach About US$ 22 Billion by 2012. Mar 8, 2008 507
Array BioPharma Announces Positive Phase 2 Top-Line Results in Inflammatory Pain Clinical Trial. Mar 3, 2008 1036
Inhibiting 5-lipoxygenase promotes prostate cancer cell death. Kiefer, Dale Jan 1, 2008 285
Clinical implications of resistance patterns against HBV-polymerase inhibitors for the treatment of chronic hepatitis B. Mauss, Stefan Dec 1, 2007 2155
Chronic kidney disease requires aggressive, integrated care. Wendling, Patrice Oct 1, 2007 408
Lipid peroxidation, cyclooxygenase enzyme and tumor cell proliferation inhibitory compounds in Cornus kousa fruits. Vareed, Shaiju K.; Schutzki, Robert E.; Nair, Muraleedharan G. Clinical report Oct 1, 2007 2004
Boehringer Ingelheim Announces First International Head-to-Head Trial of Aptivus(R) (tipranavir) versus darunavir in Treatment-Experienced HIV-Positive Patients. Jul 24, 2007 1168
Abbott Submits E.U. and U.S. Regulatory Filings for New Lower-Strength Kaletra(R) and Aluvia(R) (lopinavir/ritonavir) Tablet Suitable for Pediatric Use in HIV/AIDS. Jul 20, 2007 1666
N-terminal pro-B-type natriuretic peptide predicts total and cardiovascular mortality in individuals with or without stable coronary artery disease: the Ludwigshafen risk and cardiovascular health study. Marz, Winfried; Tiran, Beate; Seelhorst, Ursula; Wellnitz, Britta; Bauersachs, Johann; Winkelmann, B Clinical report Jun 1, 2007 7682
Gilead Announces 24-Week Results from Phase II Study of Investigational HIV Integrase Inhibitor GS 9137. Mar 1, 2007 1490
Efficacy and economics of topical calcineurin inhibitors for the treatment of atopic dermatitis. Abramovits, W.; Hung, P.; Tong, K.B. Brief article Jan 1, 2007 267
TNF inhibitors may reduce stroke, MI. Aug 15, 2006 670
Getting back at celiac: enzyme treatment might stem wheat intolerance. Brownlee, C. Jul 1, 2006 497
Duke University obtains United States patent. Brief article Jul 1, 2006 96
Hepatotoxicity risk of statins. Evans, Jeff Brief Article Jun 1, 2004 159
Compounds trigger tumor-cell suicide. Travis, John Jan 24, 2004 478
Amgen and Biovitrum sign metobolic disease license agreement. Sep 1, 2003 599
Enzyme inhibitor cuts glucose in type 2 diabetes; taken daily at breakfast. McNamara, Damian Brief Article Aug 1, 2003 267
Inhibitory activity of xanthine oxidase and superoxide-scavenging activity in some taxa of the lichen family Graphidaceae. Behera, B.C.; Adawadkar, B.; Makhija, U. Jul 1, 2003 4798
[alpha]-Asarone inhibits HMG-CoA reductase, lowers serum LDL-cholesterol levels and reduces biliary CSI in hypercholesterolemic rats. Rodriguez-Paez, L.; Juarez-Sanchez, M.; Antunez-Solis, J.; Baeza, I.; Wong, C. Jun 1, 2003 4736
Quantitative analysis of ornithine decarboxylase MRNA by reverse transcription-PCR with the LightCycler system. Orta, Xavi; Balsells, Joaquin; Olsina, Jorge; Venereo, Yusimy; Segovia-Silvestre, Toni; Farriol, Mir Oct 1, 2002 2317
Age-related underutilization of angiotensin-converting enzyme inhibitors in older hospitalized heart failure patients. Howard, George Jul 1, 2002 5810
New drugs to debut for erectile dysfunction. (Vardenafil, Tadalafil). Norton, Patrice G.W. Brief Article Jul 1, 2002 154
New HIV drugs in the pipeline: drug companies have dozens of new anti-HIV drugs under study, with many advantages--and a few drawbacks--compared with existing medications. (Health Update). Adams, Bob Statistical Data Included May 28, 2002 1445
3-Dimensional receives patent protection. Brief Article Sep 1, 2001 262
Measurement of plasma renin activity with use of HPLC-electrospray-tandem mass spectrometry. Fredline, Victoria F.; Kovacs, Eva M.; Taylor, Paul J.; Johnson, Anthony G. May 1, 1999 4167
Drugs tackle cancer in unexpected way. J.T. Brief Article Apr 10, 1999 180
Early Results of Clinical Trial Data in Diabetic Eye Study Are Promising, Joslin Researchers Report. Oct 22, 1998 927
Testing for natural aflatoxin inhibitors. Hardin, Ben Jul 1, 1998 446
FibroGen Reports Key Advances in Scarring and Regeneration. Article Jun 22, 1998 370
Triangle Pharmaceuticals Announces the Re-Initiation of Trials with DMP-450 Dec 22, 1997 443
AIDS Vaccine Effective in Animal Tests; Human HGP-30 Antibodies Shown to Recognize HIV Subtypes Dec 10, 1997 817
AIDS Vaccine Effective in Animal Tests; Human HGP-30 Antibodies Shown to Recognize HIV Subtypes Dec 10, 1997 833
Alteon and Genentech to Collaborate on Therapy for Diabetic Complications Dec 4, 1997 1068
Peptimmune Acquires Option to HIV Therapeutic Vaccine Technology From Massachusetts General Hospital Dec 2, 1997 462
Patients With Hereditary Lung Disease Eligible for Treatment in Clinical Study Dec 1, 1997 294
Bristol-Myers Squibb and Arris Pharmaceutical to Develop Hepatitis C Inhibitors Dec 1, 1997 652
Forest Laboratories Announces the Filing of a New Drug Application For Synapton for the Treatment of Alzheimer's Disease Nov 18, 1997 297
Bristol-Myers Squibb Statement Regarding the Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Nov 12, 1997 531
FDA Grants Roche Marketing Clearance for FORTOVASE(TM) (saquinavir) Nov 10, 1997 1302
Heska Enters Development Collaboration With CollaGenex for Pharmaceutical Products for Treatment of Inflammatory Diseases Nov 5, 1997 676
LXR Biotechnology Inc. Receives FDA Permission to Commence Pivotal Clinical Trial for Heart Preservation Solution(z) Nov 5, 1997 504
Medizone International To Move Forward With Human Clinical Trials Oct 21, 1997 515
Aronex Pharmaceuticals Awarded $1.1 Million In Grants Oct 20, 1997 481
Corvas Announces Issuance of U.S. Patents on Serine Protease Inhibitors Oct 20, 1997 608
CoCensys' Apoptosis Program Garners SBIR Grant Oct 16, 1997 377
Vertex Pharmaceuticals Reports Encouraging Preliminary Data from Phase II Clinical Study with HIV Protease Inhibitor 141W94 Oct 13, 1997 926
Agouron Reports Anticancer Collaboration With U.K. Organizations; Agouron to Immediately Optimize Lead Compounds Oct 2, 1997 510
VIRAMUNE Triple Combo Reduces Viral Load Below Limit of Detection In 60 Percent 0f Advanced-Stage HIV-1 Patients Sep 29, 1997 534
Viramune Triple Therapy Shows Suppression of HIV After One Year, 7 Months - Over 50% of Patients Below Limit of Detection - Sep 29, 1997 530
Aronex Presents Results for Integrase Inhibitor Zintevir(TM) at ICAAC Conference Sep 29, 1997 500
New Studies with Crixivan Presented at ICAAC: Crixivan in Triple Therapy Lowered HIV to Undetectable Levels for Two Years in Approximately 80 Percent of Patients in Merck Study 035 Sep 29, 1997 1489
Triangle Pharmaceuticals Reports Data on Increased Dosages of MKC-442 in HIV-Infected Patients Sep 29, 1997 664
Agouron's VIRACEPT Exhibits Anti-HIV Potency After 12 Months Additional Results Reported at International Meeting Sep 29, 1997 4913
Investigational Protease Inhibitor Fortovase(TM) (saquinavir) Compares Favorably in First Head-to-Head Study Sep 29, 1997 790
Vertex and Glaxo Wellcome Begin Third Phase III Pivotal Trial with HIV Protease Inhibitor 141W94 (VX-478) Sep 29, 1997 928
Dyax Corp. Issued U.S. Patent Covering Novel Elastase Inhibitors Sep 25, 1997 454
The Immune Response Corporation Presents REMUNE(TM) Data at the Second Annual Institute of Human Virology Meeting Sep 22, 1997 553
CEL-SCI Corporation and AIDS ReSEARCH Alliance Announce Results of HGP-30 AIDS Vaccine Study, Plan Further Study Sep 17, 1997 493
Tredegar's Molecumetics Subsidiary, Teijin to Collaborate On Anti-Coagulant Drug Research Sep 10, 1997 481
CollaGenex Pharmaceuticals Hires Former P&G Marketing Group For U.S. Launch Of Periostat Feb 13, 1997 660
Bak, the Bcl-2-homologous antagonist/killer, a critical modulator of apoptosis in human disease. Barr, Philip J.; Kiefer, Michael C. Nov 1, 1995 766
Backup digestive enzyme rescues insects. Adler, T. Brief Article Aug 19, 1995 465
Plants that fight back. Jun 1, 1993 445
Enzyme blocker cools inflammatory reaction. Raloff, J. May 5, 1990 600
Enzyme blockers slay AIDS 'giant.' Edwards, Diane D. Nov 7, 1987 400
Muscular dystrophy: defective inhibitor? Jan 17, 1987 346
Why did my sister get lung cancer? When a non-smoker who hasn't lived or worked around smokers gets primary lung cancer, could it be because of radon gas in the home and-or a hereditary alpha 1 antitrypsin deficiency? SerVaas, Cory Jan 1, 1987 2940

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters